phase 2_initiation
saveKyowa Kirin Co Ltd — KK-4277 (Phase II Trial Initiation)
community read0 votes
Therapy area: Immunology. Indication: Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus
Therapy area: Immunology. Indication: Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus